The difference in the median serum albumin levels between the two points was not statistically significant while median ejection fraction was significantly lower in patients with PAH at zero point than at study termination [31% (27-34) vs 50% (46-52)], p = 0.002]. The gene discussed is ALB; the disease is pulmonary arterial hypertension.